Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A report published today in the New England ...
Sep 30, 2020
0
6